On Thursday 9th February, our prestigious Steering Committee will meet in Paris to talk about BioFIT 2017.
First of all, we are honored to welcome new members in the Steering Commitee for the 2017 edition:
- Nadine Weisslinger-Darmon, Medical Director Specialty Products, Clinical Research and Academic Alliances, from GSK
- Cédric Barrière, Director, External Innovation Oncology, External Science and Partnering, from Sanofi
- Pascal Raoul, Scientific and Innovation Director, from CEVA
- Christian Policard, Member of the Board, Chairman of the Business Development Sub-Committee, from France Biotech
Composed of high level representations from leaders of the Life Sciences industry: Pfizer, Roche, Boehringer Ingelheim, Ipsen, Novo Nordisk, LFB, TTOs and Academics: Ascenion, Max Planck Institute of Molecular Cell Biology and Genetics, SATT Conectus Alsace, SATT Nord as well as Associations, Clusters, Investors & Law Firms: Sofinnova Partners, Alsace BioValley, De Gaulle Fleurance & Associés, EBE – European Biopharmaceutical Enterprises.
This BioFIT Steering Committee meeting will be the perfect way for these renowned experts to further discuss about the 2017 conference programme and identify top-notch potential speakers for the roundtable discussions.